Prediction: Pfizer Will Beat the Market in Five Years
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
This brief explains the asset selection logic behind equal weighted indices and how different asset classes impact portfolio balance.
23,793 articlesPfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
South Korea’s KOSPI dropped sharply after circuit-breaker rules kicked in, fueling anxiety about a potential spillove...
Howard Marks cautions that the AI stock rally may be more speculation than solid analysis, urging investors to anchor...
When public attention shines on young earners, smart financial habits can turn a brief spotlight into lasting wealth....
Mortgage applications rise purchase demand offset a dip in refinances as rates ease and housing inventories improve. ...
SCHD will conduct its annual reconstitution on March 23, trimming energy exposure and leaning more on financials to d...
Credo Technology Group has surged about 90% year-to-date, fueling debate on whether the rally can sustain amid new AI...
Could Amazon pull ahead of the broader market? This article builds a disciplined case for why Amazon might outperform...
Investors are spotting a familiar pattern that last showed up in 2020. This piece breaks down what the stock market j...
The S&P 500 now carries an 18% semiconductor exposure, a level unseen since the dot-com era. A handful of chipmakers ...
Micron Technology has sprinted to the high end of a price landscape after surging 814% year. As investors weigh the n...
April data from the National Association of Realtors shows pending home sales rise 1.4% month over month, underscorin...